Bouchey Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$649K Buy
1,825
+63
+4% +$22.5K 0.05% 81
2025
Q4
$577K Sell
1,762
-4
-0.2% -$1.27K 0.04% 78
2025
Q3
$498K Buy
1,766
+72
+4% +$20.9K 0.04% 82
2025
Q2
$473K Sell
1,694
-71
-4% -$20.1K 0.04% 83
2025
Q1
$550K Buy
1,765
+20
+1% +$5.91K 0.05% 71
2024
Q4
$455K Buy
1,745
+7
+0.4% +$2.08K 0.04% 83
2024
Q3
$560K Buy
1,738
+33
+2% +$10.8K 0.05% 79
2024
Q2
$532K Buy
1,705
+20
+1% +$5.88K 0.05% 75
2024
Q1
$479K Hold
1,685
0.05% 79
2023
Q4
$485K Buy
1,685
+344
+26% +$93.7K 0.05% 74
2023
Q3
$361K Buy
1,341
+360
+37% +$89.8K 0.04% 83
2023
Q2
$218K Hold
981
0.03% 104
2023
Q1
$237K Hold
981
0.03% 91
2022
Q4
$258K Buy
+981
New +$263K 0.04% 76
2022
Q2
Sell
-981
Closed -$237K 83
2022
Q1
$237K Buy
+981
New +$225K 0.03% 88

Other funds holding AMGN

Bouchey Financial Group's AMGN Position: Q1 2026 in Review

Bouchey Financial Group increased its Amgen (AMGN) stake by 3.6% in Q1 2026, buying an estimated $22.5K and bringing the position to 1,825 shares worth $649K. The position accounts for 0.05% of the portfolio, ranked #81.

Bouchey Financial Group first reported a position in AMGN in Q1 2022 and has held it in 15 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bouchey Financial Group held 1,825 shares of Amgen worth $649K as of Q1 2026.
  • Bouchey Financial Group bought 63 Amgen shares in Q1 2026, an estimated $22.5K.
  • Amgen made up 0.05% of Bouchey Financial Group's portfolio in Q1 2026, its #81 holding.
  • Bouchey Financial Group first reported a position in Amgen in Q1 2022 and has held it in 15 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bouchey Financial Group's 13F filing for Q1 2026, filed 13 Apr 2026.